Bank of Montreal’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-818
Closed -$44K – 4655
2016
Q1
$44K Sell
818
-1,863
-69% -$138K ﹤0.01% 3107
2015
Q4
$303K Buy
2,681
+494
+23% +$54.4K ﹤0.01% 2195
2015
Q3
$257K Sell
2,187
-10,763
-83% -$1.41M ﹤0.01% 2145
2015
Q2
$1M Buy
+12,950
New +$849K ﹤0.01% 1666
2015
Q1
– Sell
-15,000
Closed -$484K – 4473
2014
Q4
$484K Buy
+15,000
New +$450K ﹤0.01% 2075
2014
Q3
– Sell
-3,640
Closed -$65K – 4995
2014
Q2
$65K Buy
3,640
+640
+21% +$10.3K ﹤0.01% 3089
2014
Q1
$60K Sell
3,000
-3,000
-50% -$58.2K ﹤0.01% 3051
2013
Q4
$101K Sell
6,000
-4,000
-40% -$55.3K ﹤0.01% 2537
2013
Q3
$106K Hold
10,000
– – ﹤0.01% 2486
2013
Q2
$56K Buy
+10,000
New +$60.5K ﹤0.01% 2680

Other funds holding ANAC

Bank of Montreal's ANAC Position: Q2 2016 in Review

Bank of Montreal sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 818 shares — an estimated $44K sold.

Bank of Montreal first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $1M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Bank of Montreal reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Bank of Montreal sold 818 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $44K.
  • Bank of Montreal first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
  • Bank of Montreal's ANACOR PHARMACEUTICALS INC COM position peaked at $1M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Bank of Montreal's 13F filing for Q2 2016, filed 25 Jul 2016.